
Life sciences investment arm of Blackstone funding pharmaceutical, biotech and medical technology companies

Tokyo investment firm managing funds and supporting technology commercialisation and overseas expansion

Japan Strategic Capital Co., Ltd. is an investment company that puts money into companies and technologies whose value is not yet widely recognised. It works alongside entrepreneurs and researchers. The team describes itself as bridging Japanese resources with other parts of the world.
The firm helps Japanese companies and technologies go global, and brings foreign companies and technologies into Japan. Recent deals include an investment in Chekkit, a Nigerian company that uses blockchain to fight counterfeit goods.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
As of 2026-10-11. Organic ranks only; sponsored placements are never ranks.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Japan Strategic Capital.
Similar listings buyers compare against this one.

Life sciences investment arm of Blackstone funding pharmaceutical, biotech and medical technology companies

Oslo-based private investment company backing early and later-stage life science businesses

Healthcare venture fund backed by Blue Cross Blue Shield plans, investing in emerging health companies

Seed-only venture firm backing engineering-minded founders with equity or SAFE investments

Early-stage venture fund backing seed and Series A founders in the US and Europe

Hong Kong investment group backing fintech and technology companies worldwide with hands-on support
Everything here links back to the same verified catalogue. Pick your next stop.